Table 2.
Treatment during hospital stay and at discharge of the three patient groups
Normal glucose tolerance (n=78) | Abnormal glucose tolerance (n=112) | Diabetes mellitus (n=85) | p Value | |
Thrombolysis | 3 (4%) | 3 (3%) | 6 (7%) | 0.32 |
Primary PCI | ||||
POBA | 22 (28%) | 30 (27%) | 17 (20%) | 0.42 |
Stents | 45 (58%) | 70 (63%) | 51 (60%) | 0.80 |
Aspirin | 76 (97%) | 110 (98%) | 82 (96%) | 0.74 |
Ticlopidine | 44 (56%) | 66 (59%) | 48 (56%) | 0.92 |
β-blockers | 60 (77%) | 95 (85%) | 70 (82%) | 0.38 |
ACE inhibitors | 64 (82%) | 89 (79%) | 74 (87%) | 0.38 |
Calcium channel blockers | 14 (18%) | 12 (11%) | 14 (16%) | 0.32 |
Diuretics | 8 (10%) | 12 (11%) | 13 (15%) | 0.53 |
Statin | 20 (26%) | 46 (41%) | 24 (28%) | 0.05 |
Oral hypoglycemic agents | 0 (0%) | 20 (18%) | 66 (78%) | <0.0001 |
Insulin therapy | 0 (0%) | 0 (0%) | 6 (7%) | 0.004 |
Data are n (%) unless otherwise indicated.
CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; POBA, plain old balloon angioplasty.